Gene therapies have seen a drop in investor interest lately. Despite this, Kriya Therapeutics seems to be attracting funds in ...

Discover the top biotech deals of August 2025, as several big pharmas shopped around, especially in the field of small ...

Discover how in some communities around the world, the prevalence of rare diseases is higher due to factors like cousin ...

As the release of a CRL declining Lykos' therapy generates a strong reaction from MAPS, delve into what this new transparency ...

As radiopharma is gaining momentum, read our interview with Dr. Delpassand, the CEO of RadioMedix's, an established company ...

Once thought to be under control, yellow fever is making an alarming comeback, and the numbers are climbing. With treatment ...

Kriya Therapeutics, Strand Therapeutics, and Minghui Pharmaceutical bagged the biggest biotech funding rounds overall in ...

As September marks the beginning of Blood Cancer Awareness Month, delve into what is being developed in the biotech pipelines.

Multichain biotherapeutics continue to be a promising therapeutic modality. “These therapeutic recombinant proteins are typically assembled from at least three distinct polypeptide chains,” says ...